Thread by @mirvatalasnag

Thank u @Heart_SCCT @jolson106

Was an honor serving on #ASM committee #SCCT2022 & congrats @ghoshhajra for leading this team

My takeaways:
1) #ISCHEMIA captured current landscape of functional testing & put anatomy vs ischemia discussions in the center

ahajournals.org/doi/10.1161/CI…

2) We learned from those excluded from the trial as much as we did from those included #CIAO-ISCHEMIA

#SCCT2022

ahajournals.org/doi/10.1161/CI…

3) #DISCHARGE trial will make way for cathlabs to focus on complex procedures as #YesCCT assumes most diagnostic evaluations

nejm.org/doi/full/10.10…

#SCCT2022 @NEJM

4.#FFRCT pro & cons: provides spectrum of ischemia rather than a binary yes/no & it is a work in progress
#PACIFICTrial long term results anticipated

sciencedirect.com/science/articl…

#SCCT2022

5.Plaque characterization provides more than % stenosis & a step in the direction of vulnerable plaque/patient. Work in progress. #SCCT2022

6.#CACS how it compares to current functional testing & it’s NPV.. CON-beyond calcium: % stenosis, consistency & early detection/prevention

#SCOTHEART nejm.org/doi/full/10.10… @NEJM

#SCCT2022

7. #PROMISE #SCCT2022 How age is factored into the decision making

@JAMANetwork
jamanetwork.com/journals/jamac…

Finally: #Advocacy #SCCT2022 @Heart_SCCT @EricWillMD

-Aligned w @ACCinTouch @ditchhaporia
-Create educational dossier to speak same language
-Advocate reimbursement

Slide courtesy @Ahmad_M_Slim

@bjcohenmd @HeartOTXHeartMD

@threadreaderapp unroll